AAM
RARE icon

Advisors Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Advisors Asset Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,376
Closed -$577K – 1551
2020
Q2 		$577K Sell
7,376
-5,443
-42% -$360K 0.01% 864
2020
Q1 		$570K Sell
12,819
-668
-5% -$34.7K 0.01% 782
2019
Q4 		$576K Sell
13,487
-399
-3% -$16.5K 0.01% 941
2019
Q3 		$594K Sell
13,886
-810
-6% -$44K 0.01% 926
2019
Q2 		$933K Sell
14,696
-455
-3% -$29K 0.02% 806
2019
Q1 		$1.05M Sell
15,151
-282
-2% -$16.1K 0.02% 807
2018
Q4 		$671K Buy
15,433
+3,920
+34% +$214K 0.01% 900
2018
Q3 		$879K Buy
11,513
+9,158
+389% +$745K 0.01% 882
2018
Q2 		$181K Buy
+2,355
New +$152K ﹤0.01% 1275

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return